AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Kane Biotech Inc.

CAD 0.03 -$0.01 (-25.00%)
TSXV · 14 Sep 2026 17:44 UTC
Previous Close
CAD 0.03
Day Range
CAD 0.03 - CAD 0.03
Year Range
CAD 0.02CAD 0.05
Market Cap
6.15M
AVG Volume
147.6K
Trailing/Forward PE
-2.05/-
PEG ratio
0.07
Dividend Yield
-
Next Earnings Date
2026-11-26
Primary Exchange
Toronto Stock Exchange VenturesCA
Revenue (CAD) · TTM
01M2M3M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KNE.V Revenue (CAD) · TTM by quarter
PeriodRevenue (CAD) · TTM
26 Q238.72K
26 Q158.57K
25 Q4427.87K
25 Q3574.87K
25 Q21.85M
25 Q12.44M
24 Q42.08M
24 Q31.32M
24 Q2757.11K
24 Q1793.99K
Net Income (CAD) · TTM
-10M-5M05M10M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KNE.V Net Income (CAD) · TTM by quarter
PeriodNet Income (CAD) · TTM
26 Q2-2.7M
26 Q1-2.22M
25 Q4-2.72M
25 Q3-1.95M
25 Q2-1.95M
25 Q17.59M
24 Q47.41M
24 Q35.6M
24 Q24.83M
24 Q1-5.32M
Operating Income (CAD) · TTM
-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KNE.V Operating Income (CAD) · TTM by quarter
PeriodOperating Income (CAD) · TTM
26 Q2-3.14M
26 Q1-2.63M
25 Q4-3.11M
25 Q3-3.08M
25 Q2-3.15M
25 Q1-3.98M
24 Q4-4M
24 Q3-3.93M
24 Q2-4.52M
24 Q1-3.95M
EBITDA (CAD) · TTM
-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KNE.V EBITDA (CAD) · TTM by quarter
PeriodEBITDA (CAD) · TTM
26 Q2-3.07M
26 Q1-2.5M
25 Q4-2.95M
25 Q3-2.77M
25 Q2-2.83M
25 Q1-3.7M
24 Q4-3.71M
24 Q3-3.72M
24 Q2-4.26M
24 Q1-3.67M
Cash Flows (CAD) · TTM
-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KNE.V Cash Flows (CAD) · TTM by quarter
PeriodCash Flows (CAD) · TTM
26 Q2-2.42M
26 Q1-2.61M
25 Q4-3.26M
25 Q3-3.09M
25 Q2-2.94M
25 Q1-4.32M
24 Q4-4.16M
24 Q3-5.67M
24 Q2-5.87M
24 Q1-3.35M
EPS (CAD) · TTM
-0.05-0.0300.030.0524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KNE.V EPS (CAD) · TTM by quarter
PeriodEPS (CAD) · TTM
26 Q2-0.01
26 Q1-0.01
25 Q4-0.02
25 Q3-0.01
25 Q2-0.01
25 Q10.05
24 Q40.04
24 Q30.03
24 Q20.02
24 Q1-0.04
Expenses (CAD) · TTM
-2M02M4M6MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KNE.V Expenses (CAD) · TTM by quarter
PeriodExpenses (CAD) · TTM
26 Q22.78M
26 Q12.29M
25 Q42.86M
25 Q33.06M
25 Q23.7M
25 Q14.92M
24 Q44.9M
24 Q34.73M
24 Q25.1M
24 Q14.53M
Shares Outstanding (CAD) · TTM
-1M-500K0500KBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KNE.V Shares Outstanding (CAD) · TTM by quarter
PeriodShares Outstanding (CAD) · TTM
26 Q2-107.8K
26 Q1130.93K
25 Q40
25 Q3-71.75K
25 Q2-187.96K
25 Q1-633.43K
24 Q4-710.83K
24 Q3-765.96K
24 Q2-855.81K
24 Q1-683.03K
PE Ratio
01234med 2.01Oct 24Dec 24Feb 25Apr 25Jun 25Aug 25Sep 25
KNE.V PE Ratio by quarter
PeriodPE Ratio
Sep 250.99
Sep 250.79
Sep 250.79
Sep 250.79
Aug 250.84
Aug 250.84
Aug 250.89
Aug 250.79
Aug 250.79
Jul 250.89
Jul 250.89
Jul 250.99
Jul 250.99
Jun 251.02
Jun 251.02
Jun 251.12
Jun 250.93
May 250.93
May 251.02
May 251.12
May 251.49
May 251.49
Apr 251.77
Apr 251.67
Apr 251.86
Apr 251.86
Mar 252.15
Mar 252.75
Mar 252.51
Mar 252.27
Feb 252.39
Feb 252.39
Feb 252.63
Feb 252.51
Jan 252.63
Jan 252.51
Jan 252.39
Jan 252.63
Jan 252.63
Dec 242.74
Dec 242.74
Dec 243.15
Dec 242.88
Nov 243.43
Nov 243.02
Nov 242.88
Nov 242.74
Nov 243.57
Oct 243.7
Oct 243.57
Oct 243.57
Oct 243.84
Free Cash Flow Yield
-80%-60%-40%-20%med -47.85%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
KNE.V Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-47.85%
Sep 26-47.85%
Sep 26-57.42%
Aug 26-47.85%
Aug 26-47.85%
Aug 26-47.85%
Aug 26-47.85%
Jul 26-57.42%
Jul 26-57.42%
Jul 26-47.85%
Jul 26-47.85%
Jul 26-47.85%
Jun 26-66.99%
Jun 26-66.99%
Jun 26-66.99%
Jun 26-66.99%
May 26-50.24%
May 26-50.24%
May 26-57.42%
May 26-57.42%
May 26-57.42%
Apr 26-57.42%
Apr 26-66.99%
Apr 26-66.99%
Apr 26-66.99%
Mar 26-61.62%
Mar 26-61.62%
Mar 26-52.82%
Mar 26-52.82%
Feb 26-46.22%
Feb 26-46.22%
Feb 26-46.22%
Feb 26-46.22%
Jan 26-46.22%
Jan 26-46.22%
Jan 26-41.08%
Jan 26-46.22%
Jan 26-46.22%
Dec 25-45.12%
Dec 25-51.56%
Dec 25-51.56%
Dec 25-51.56%
Nov 25-51.56%
Nov 25-60.15%
Nov 25-45.12%
Nov 25-60.15%
Oct 25-60.15%
Oct 25-51.56%
Oct 25-45.12%
Oct 25-45.12%
Oct 25-40.1%
Sep 25-57.6%
Sep 25-72%
Sep 25-72%
Sep 25-72%
Aug 25-67.77%
Aug 25-67.77%
Aug 25-64%
Aug 25-72%
Aug 25-72%
Jul 25-64%
Jul 25-64%
Jul 25-57.6%
Jul 25-57.6%
Jun 25-54.96%
Jun 25-54.96%
Jun 25-50.38%
Jun 25-60.45%
May 25-60.45%
May 25-54.96%
May 25-50.38%
May 25-37.78%
May 25-37.78%
Apr 25-31.82%
Apr 25-33.58%
Apr 25-30.23%
Apr 25-30.23%
Mar 25-47.09%
Mar 25-36.85%
Mar 25-40.36%
Mar 25-44.61%
Feb 25-42.38%
Feb 25-42.38%
Feb 25-38.53%
Feb 25-40.36%
Jan 25-38.53%
Jan 25-40.36%
Jan 25-42.38%
Jan 25-38.53%
Jan 25-38.53%
Dec 24-44.36%
Dec 24-44.36%
Dec 24-38.58%
Dec 24-42.25%
Nov 24-35.49%
Nov 24-40.33%
Nov 24-42.25%
Nov 24-44.36%
Nov 24-34.12%
Oct 24-32.86%
Price to Sales
0255075100med 10.63Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
KNE.V Price to Sales by quarter
PeriodPrice to Sales
Sep 2693.14
Sep 2693.14
Sep 2677.62
Aug 2693.14
Aug 2693.14
Aug 2693.14
Aug 2693.14
Jul 2677.62
Jul 2677.62
Jul 2693.14
Jul 2693.14
Jul 2693.14
Jun 2611.37
Jun 2611.37
Jun 2611.37
Jun 2611.37
May 2615.17
May 2615.17
May 2613.27
May 2613.27
May 2613.27
Apr 2613.27
Apr 2611.37
Apr 2611.37
Apr 2611.37
Mar 268.73
Mar 268.73
Mar 2610.19
Mar 2610.19
Feb 2611.64
Feb 2611.64
Feb 2611.64
Feb 2611.64
Jan 2611.64
Jan 2611.64
Jan 2613.1
Jan 2611.64
Jan 2611.64
Dec 253.53
Dec 253.09
Dec 253.09
Dec 253.09
Nov 253.09
Nov 252.64
Nov 253.53
Nov 252.64
Oct 252.64
Oct 253.09
Oct 253.53
Oct 253.53
Oct 253.97
Sep 253.07
Sep 252.46
Sep 252.46
Sep 252.46
Aug 252.61
Aug 252.61
Aug 252.77
Aug 252.46
Aug 252.46
Jul 252.77
Jul 252.77
Jul 253.07
Jul 253.07
Jun 253.64
Jun 253.64
Jun 253.97
Jun 253.31
May 253.31
May 253.64
May 253.97
May 255.3
May 255.3
Apr 256.29
Apr 255.96
Apr 256.62
Apr 256.62
Mar 259.11
Mar 2511.64
Mar 2510.63
Mar 259.61
Feb 2510.12
Feb 2510.12
Feb 2511.13
Feb 2510.63
Jan 2511.13
Jan 2510.63
Jan 2510.12
Jan 2511.13
Jan 2511.13
Dec 2417.48
Dec 2417.48
Dec 2420.1
Dec 2418.36
Nov 2421.85
Nov 2419.23
Nov 2418.36
Nov 2417.48
Nov 2422.73
Oct 2423.6
Price to Book
050100150med 25.65Jul 20Oct 20Jan 21May 21Aug 21Dec 21Sep 23
KNE.V Price to Book by quarter
PeriodPrice to Book
Sep 231.28
Sep 231.12
Sep 231.28
Sep 231.28
Aug 231.28
Aug 231.28
Aug 231.28
Aug 231.44
Jul 231.44
Jul 231.44
Jul 231.44
Jul 231.6
Jun 231.44
Dec 2163.15
Dec 2159.43
Dec 2159.43
Dec 2163.15
Nov 2163.15
Nov 2163.15
Nov 2155.72
Nov 2159.43
Oct 2163.15
Oct 2159.43
Oct 2163.15
Oct 2163.15
Oct 2166.86
Sep 2166.33
Sep 2166.33
Sep 2162.84
Sep 2155.85
Aug 2155.85
Aug 2159.35
Aug 2159.35
Aug 2162.84
Jul 2159.35
Jul 2162.84
Jul 2159.35
Jul 2162.84
Jul 2162.84
Jun 2118.1
Jun 2117.1
Jun 2119.11
Jun 2118.1
May 2119.11
May 2119.11
May 2120.11
May 2120.11
Apr 2122.13
Apr 2119.11
Apr 2120.11
Apr 2117.1
Apr 2118.1
Mar 218.8
Mar 217.7
Mar 217.7
Mar 217.15
Feb 217.7
Feb 216.6
Feb 217.15
Feb 217.7
Jan 217.15
Jan 217.7
Jan 217.7
Jan 217.7
Dec 207.7
Dec 20100.78
Dec 20100.78
Dec 20115.18
Dec 20100.78
Nov 20115.18
Nov 20100.78
Nov 20107.98
Nov 20100.78
Oct 20100.78
Oct 20100.78
Oct 20115.18
Oct 20107.98
Oct 20115.18
Sep 2028.31
Sep 2030.08
Sep 2024.77
Sep 2028.31
Aug 2030.08
Aug 2030.08
Aug 2028.31
Aug 2028.31
Jul 2030.08
Jul 2030.08
Jul 2030.08
Jul 2024.77
Jul 2026.54
Jun 2017.85
Jun 2018.97
Jun 2017.85
Jun 2015.62
May 2015.62
May 2015.62
May 2015.62
May 2015.62
May 2015.62
Kane Biotech Inc.
KNE.V
Stockpicker

Video analysis: KNE.V

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: KNE.V

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.